Kansas legislation · 2025-2026 Regular Session
Kansas HB2159: Exempting law enforcement agencies who do not provide emergency opioid antagonistspursuant to the statewide protocol from the requirement to procure a physician medical director
Status: Passed one chamber, April 10, 2026
What the bill says
An act concerning law enforcement; relating to emergency opioid antagonists; creating the emergency opioid antagonists assistance grant fund to assist law enforcement agencies with purchasing emergency opioid antagonists; maintaining immunity for law enforcement agencies and officers for damages resulting from administering an emergency opioid antagonist; removing law enforcement agencies and officers from the state board of pharmacy's statewide opioid antagonist protocol; amending K.S.A. 2024 Supp. 65-16,127 and repealing the existing section.
From the introduced text, January 30, 2025:
AN ACT concerning law enforcement; relating to emergency opioid antagonists; creating the emergency opioid antagonists assistance grant fund to assist law enforcement agencies with purchasing emergency opioid antagonists; maintaining immunity for law enforcement agencies and officers for damages resulting from administering an emergency opioid antagonist; removing law enforcement agencies and officers from the state board of pharmacy's statewide opioid antagonist protocol; amending K.S.A. 2024 Supp. 65-16,127 and repealing the existing section. Be it enacted by the Legislature of the State of Kansas: New Section 1. (a) There is hereby established in the state treasury the emergency opioid antagonists assistance grant fund, to be administered by the attorney general. All moneys credited to the fund shall be for providing assistance to law enforcement agencies across the state in purchasing emergency opioid antagonists. (2) All expenditures from the emergency opioid antagonists assistance account grant fund shall be made in accordance with appropriation acts upon warrants of the director of accounts and reports issued pursuant to vouchers approved by the attorney general or the attorney general's designee. (c) The attorney general shall develop and implement the emergency opioid antagonists assistance grant program with the goal of providing assistance to law enforcement agencies across the state in purchasing emergency opioid antagonists for law enforcement officers to carry while such officers are on duty. Prioritization …